Kestra Medical Technologies (NASDAQ:KMTS) Now Covered by Analysts at The Goldman Sachs Group

The Goldman Sachs Group began coverage on shares of Kestra Medical Technologies (NASDAQ:KMTS) in a report published on Monday, MarketBeat reports. The brokerage issued a neutral rating and a $24.00 price target on the stock.

Separately, Stifel Nicolaus assumed coverage on shares of Kestra Medical Technologies in a research report on Monday. They issued a “buy” rating and a $28.00 price target on the stock. One research analyst has rated the stock with a hold rating and five have issued a buy rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $27.67.

Kestra Medical Technologies Stock Performance

NASDAQ:KMTS opened at $24.92 on Monday. Kestra Medical Technologies has a 1-year low of $20.00 and a 1-year high of $25.98.

Kestra Medical Technologies Company Profile

We are a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. We have developed and are commercializing our Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution.